Innovative atherosclerosis imaging using 18F-NaF PET/CT: Its clinical potential
- PMID: 33686582
- DOI: 10.1007/s12350-021-02576-z
Innovative atherosclerosis imaging using 18F-NaF PET/CT: Its clinical potential
Comment on
-
Longitudinal analysis of atherosclerotic plaques evolution: an 18F-NaF PET/CT study.J Nucl Cardiol. 2022 Aug;29(4):1713-1723. doi: 10.1007/s12350-021-02556-3. Epub 2021 Feb 25. J Nucl Cardiol. 2022. PMID: 33630243
References
-
- Derlin T, Tóth Z, Papp L, Wisotzki C, Apostolova I, Habermann CR, et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual tracer PET/CT study. J Nucl Med. 2011;52:1020-7. - DOI
-
- Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539-48. - DOI
-
- Lee JM, Bang JI, Koo BK, Hwang D, Park J, Zhang J, et al. Clinical relevance of 18F-sodium fluoride positron-emission tomography in noninvasive identification of high-risk plaque in patients with coronary artery disease. Circ Cardiovasc Imaging. 2017;10:e006704. - DOI
-
- Kitagawa T, Yamamoto H, Toshimitsu S, Sasaki K, Senoo A, Kubo Y, et al. 18F-sodium fluoride positron emission tomography for molecular imaging of coronary atherosclerosis based on computed tomography analysis. Atherosclerosis. 2017;263:385-92. - DOI
-
- Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, Craighead FH, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet. 2014;383:705-13. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
